Dogwood Therapeutics, Inc. (DWTX) — Cash Flow-to-Debt Ratio
Dogwood Therapeutics, Inc. (DWTX) has a Cash Flow-to-Debt Ratio of -0.22x as of September 2025, meaning its operating cash flow of $-3.27 Million could theoretically repay 0% of its total liabilities ($14.61 Million) in one year. See Dogwood Therapeutics, Inc. (DWTX) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Dogwood Therapeutics, Inc. Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for Dogwood Therapeutics, Inc. across 7 annual periods. Also explore Dogwood Therapeutics, Inc. annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Dogwood Therapeutics, Inc. (2018–2024)
Year-by-year debt coverage analysis for Dogwood Therapeutics, Inc.. For market capitalisation and broader financial context, see DWTX market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.29x | $-8.79 Million | $30.03 Million | ▲ +97.8% |
| 2023 | -13.58x | $-4.87 Million | $358.55K | ▼ -23.6% |
| 2022 | -10.99x | $-11.47 Million | $1.04 Million | ▲ +10.6% |
| 2021 | -12.30x | $-15.69 Million | $1.28 Million | ▼ -383.7% |
| 2020 | -2.54x | $-3.90 Million | $1.53 Million | ▼ -539.1% |
| 2019 | -0.40x | $-2.09 Million | $5.26 Million | ▲ +55.9% |
| 2018 | -0.90x | $-1.20 Million | $1.33 Million | — |